RicercaInizia una nuova ricerca
NOTA: è possibile cercare una corrispondenza esatta usando i doppi apici, ad es: "evoluzione della specie". Qualora si cerchi un identificativo, è consigliabile cercarlo in due modi differenti: tra apici con caratteri speciali es: "978-94-6366-274" oppure senza caratteri speciali solo come sequenza numerica: es 978946366274.
A Mouse Model of Telomere Dysfunction Recapitulates Hallmark Features of Human Myelodysplastic Syndrome
2014-01-01 Colla, Simona; Ong, Derrick; Ogoti, Yamini; Marchesini, Matteo; Mistry, Nipun; Clise Dwyer, Karen; Storti, Paola; Viale, Andrea; Wei, Yue; Giuliani, Nicola; Yang, Hui; D'Anca, Marianna; Estecio, Marcos R.; Liang, Han; Kantarjian, Hagop M.; Wang, Alan Y.; Chin, Lynda; Bueso Ramos, Carlos E.; Garcia Manero, Guillermo; Depinho, Ronald
A Phase I/II Study of Pomalidomide-Cyclophosphamide-Prednisone (PCP) in Patients with Multiple Myeloma Relapsed/Refractory to Lenalidomide
2011-01-01 Palumbo, A; Larocca, A; Carella, Am; Rossi, D; Montefusco, V; Ferrari, S; Santagostino, A; Guglielmelli, T; Galli, M; Capaldi, A; Giuliani, Nicola; La Verde, G; Omedè, P; Baldi, I; Boccadoro, M; Corradini, P.
A Phase I/II, multi-center, open label study of Pomalidomide, Cyclophosphamide and Prednisone (PCP) in patients with multiple myeloma relapsed and/or refractory to Lenalidomide
2013-01-01 Mina, R; Larocca, A; Montefusco, V; Gay, F; De Paoli, L; Crippa, C; Cavallo, F; Galli, M; Marcatti, M; Moscetti, A; Giuliani, Nicola; Guglielmelli, T; Rota Scalabrini, D; Caltagirone, S; Santagostino, A; Baldi, I; Spriano, M; Boccadoro, M; Corradini, P; Palumbo, A.
A Randomized Phase 3 trial of Melphalan-Lenalidomide-Prednisone (MPR) or Cyclophosphamide-Prednisone-Lenalidomide (CPR) vs Lenalidomide plus Dexamethsone (Rd) in elderly newly diagnosed multiple myeloma patients
2013-01-01 Palumbo A, Magarotto V; Bringhen, S; Offidani, M; Pietrantuono, G; Liberati, Am; Benevolo, G; M, Ledda A. Gilestro; Galli, M; Patriarca, F; Genuardi, M; Giuliani, Nicola; Zambello, R; Zdenek, A; La Fauci, A; Corradini, P; Falcone, Ap; Musolino, C; Rossi, D; Caraffa, P; Musto, P; Cavallo, F; Hajek, R; Boccadoro, M.
Activation of non-canonical wnt pathway in human mesenchymal cells affects osteogenic differentiation: a potential target in Multiple Myeloma microenvironment
2008-01-01 Giuliani, Nicola; Colla, S; Storti, Paola; Donofrio, Gaetano; Bolzoni, Marina; Bonomini, S; Galla, L; Sammarelli, Gabriella; Mangoni, M; Rizzoli, Vittorio
Addition of Bortezomib to High Dose Melphalan As Conditioning Regimen for Autologous Stem Cell Transplantation Improves the Response Rate in Newly Diagnosed Multiple Myeloma Patients
2016-01-01 Benedetta, Dalla Palma; Prezioso, Lucia; Accardi, Fabrizio; Stefano, Bisbano; DE LUCA, Federica; Aversa, Franco; Giuliani, Nicola
Adenosine and ectoenzymes in myeloma life and survival in the bone marrow niche
2014-01-01 Horenstein, Alberto; Quarona, Valeria; Chillemi, Antonella; Zaccarello, Gianluca; Morandi, Fabio; Pistoia, Vito; Giuliani, Nicola; Malavasi, Fabio
ADENOSINE IN THE MYELOMA BONE MARROW NICHE: IMMUNE CHECKPOINT AND KEY PLAYER IN DISEASE PROGRESSION
2017-01-01 Horenstein, A; Chillemi, A; Quarona, V; Costa, Federica; Toscani, Denise; Morandi, F; Marimpietro, D; Giuliani, Nicola; Malavasi, F.
Alterations of microenvironment in multiple myeloma patients: Interactions between myeloma cells and osteoprogenitor cells
2009-01-01 Giuliani, N.; Rizzoli, V.
Amlexanox inhibition of TBK1/IKK epsilon Signaling Is a Novel Therapeutic Approach for Multiple Myeloma-Induced Bone Disease.
2017-01-01 Sun, Qh; Zhang, P; Adamik, J; Marchica, V; Giuliani, N; Silbermann, R; Roodman, Gd; Galson, Dl
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A Mouse Model of Telomere Dysfunction Recapitulates Hallmark Features of Human Myelodysplastic Syndrome | 1-gen-2014 | Colla, Simona; Ong, Derrick; Ogoti, Yamini; Marchesini, Matteo; Mistry, Nipun; Clise Dwyer, Karen; Storti, Paola; Viale, Andrea; Wei, Yue; Giuliani, Nicola; Yang, Hui; D'Anca, Marianna; Estecio, Marcos R.; Liang, Han; Kantarjian, Hagop M.; Wang, Alan Y.; Chin, Lynda; Bueso Ramos, Carlos E.; Garcia Manero, Guillermo; Depinho, Ronald | |
| A Phase I/II Study of Pomalidomide-Cyclophosphamide-Prednisone (PCP) in Patients with Multiple Myeloma Relapsed/Refractory to Lenalidomide | 1-gen-2011 | Palumbo, A; Larocca, A; Carella, Am; Rossi, D; Montefusco, V; Ferrari, S; Santagostino, A; Guglielmelli, T; Galli, M; Capaldi, A; Giuliani, Nicola; La Verde, G; Omedè, P; Baldi, I; Boccadoro, M; Corradini, P. | |
| A Phase I/II, multi-center, open label study of Pomalidomide, Cyclophosphamide and Prednisone (PCP) in patients with multiple myeloma relapsed and/or refractory to Lenalidomide | 1-gen-2013 | Mina, R; Larocca, A; Montefusco, V; Gay, F; De Paoli, L; Crippa, C; Cavallo, F; Galli, M; Marcatti, M; Moscetti, A; Giuliani, Nicola; Guglielmelli, T; Rota Scalabrini, D; Caltagirone, S; Santagostino, A; Baldi, I; Spriano, M; Boccadoro, M; Corradini, P; Palumbo, A. | |
| A Randomized Phase 3 trial of Melphalan-Lenalidomide-Prednisone (MPR) or Cyclophosphamide-Prednisone-Lenalidomide (CPR) vs Lenalidomide plus Dexamethsone (Rd) in elderly newly diagnosed multiple myeloma patients | 1-gen-2013 | Palumbo A, Magarotto V; Bringhen, S; Offidani, M; Pietrantuono, G; Liberati, Am; Benevolo, G; M, Ledda A. Gilestro; Galli, M; Patriarca, F; Genuardi, M; Giuliani, Nicola; Zambello, R; Zdenek, A; La Fauci, A; Corradini, P; Falcone, Ap; Musolino, C; Rossi, D; Caraffa, P; Musto, P; Cavallo, F; Hajek, R; Boccadoro, M. | |
| Activation of non-canonical wnt pathway in human mesenchymal cells affects osteogenic differentiation: a potential target in Multiple Myeloma microenvironment | 1-gen-2008 | Giuliani, Nicola; Colla, S; Storti, Paola; Donofrio, Gaetano; Bolzoni, Marina; Bonomini, S; Galla, L; Sammarelli, Gabriella; Mangoni, M; Rizzoli, Vittorio | |
| Addition of Bortezomib to High Dose Melphalan As Conditioning Regimen for Autologous Stem Cell Transplantation Improves the Response Rate in Newly Diagnosed Multiple Myeloma Patients | 1-gen-2016 | Benedetta, Dalla Palma; Prezioso, Lucia; Accardi, Fabrizio; Stefano, Bisbano; DE LUCA, Federica; Aversa, Franco; Giuliani, Nicola | |
| Adenosine and ectoenzymes in myeloma life and survival in the bone marrow niche | 1-gen-2014 | Horenstein, Alberto; Quarona, Valeria; Chillemi, Antonella; Zaccarello, Gianluca; Morandi, Fabio; Pistoia, Vito; Giuliani, Nicola; Malavasi, Fabio | |
| ADENOSINE IN THE MYELOMA BONE MARROW NICHE: IMMUNE CHECKPOINT AND KEY PLAYER IN DISEASE PROGRESSION | 1-gen-2017 | Horenstein, A; Chillemi, A; Quarona, V; Costa, Federica; Toscani, Denise; Morandi, F; Marimpietro, D; Giuliani, Nicola; Malavasi, F. | |
| Alterations of microenvironment in multiple myeloma patients: Interactions between myeloma cells and osteoprogenitor cells | 1-gen-2009 | Giuliani, N.; Rizzoli, V. | |
| Amlexanox inhibition of TBK1/IKK epsilon Signaling Is a Novel Therapeutic Approach for Multiple Myeloma-Induced Bone Disease. | 1-gen-2017 | Sun, Qh; Zhang, P; Adamik, J; Marchica, V; Giuliani, N; Silbermann, R; Roodman, Gd; Galson, Dl |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Opzioni
Scopri
Tipologia
- 1 Articolo su rivista 126
- 1 Articolo su rivista::1.5 Abstra... 126
Data di pubblicazione
- 2010 - 2017 73
- 2000 - 2009 52
- 1999 - 1999 1
Rivista
- BLOOD 67
- HAEMATOLOGICA 44
- EXPERIMENTAL HEMATOLOGY 9
- JOURNAL OF BONE AND MINERAL RESEARCH 2
- AMINO ACIDS 1
- BONE 1
- HEMATOLOGY MEETING REPORTS 1
- PURINERGIC SIGNALLING 1
Lingua
- eng 71
- ita 1
Accesso al fulltext
- no fulltext 126